To examine whether the twofold increase in PR72 expression observed in human heart failure functions as a compensatory mechanism to offset contractile dysfunction, we generated a transgenic mouse model that specifically overexpresses PP2A-PR72 in the heart. This evidence concerns the gene PTPA and heart failure.